Cited by 111Pregnancy and preeclampsia studiesCongenital heart defects researchBirth, Development, and Health

Chronic Hypoxemia in Late Gestation Decreases Cardiomyocyte Number but Does Not Change Expression of Hypoxia‐Responsive Genes

Open access
Botting, Kimberley J., McMillen, I. Caroline, Forbes, Heather, Nyengaard, Jens R., Morrison, Janna L.·2014·Journal of the American Heart Association

Abstract

Background: Placental insufficiency is the leading cause of intrauterine growth restriction in the developed world and results in chronic hypoxemia in the fetus. Oxygen is essential for fetal heart development, but a hypoxemic environment in utero can permanently alter development of cardiomyocytes. The present study aimed to investigate the effect of placental restriction and chronic hypoxemia on total number of cardiomyocytes, cardiomyocyte apoptosis, total length of coronary capillaries, and expression of genes regulated by hypoxia. Methods and Results: We induced experimental placental restriction from conception, which resulted in fetal growth restriction and chronic hypoxemia. Fetal hearts in the placental restriction group had fewer cardiomyocytes, but interestingly, there was no difference in the percentage of apoptotic cardiomyocytes; the abundance of the transcription factor that mediates hypoxia‐induced apoptosis, p53; or expression of apoptotic genes Bax and Bcl2 . Likewise, there was no difference in the abundance of autophagy regulator beclin 1 or expression of autophagic genes BECN1 , BNIP3 , LAMP1 , and MAP1LC3B . Furthermore, fetuses exposed to normoxemia (control) or chronic hypoxemia ( placental restriction ) had similar mRNA expression of a suite of hypoxia‐inducible factor target genes, which are essential for angiogenesis ( VEGF , Flt1 , Ang1 , Ang2 , and Tie2 ), vasodilation ( iNOS and Adm ), and glycolysis ( GLUT1 and GLUT3 ). In addition, there was no change in the expression of PKC‐ε, a cardioprotective gene with transcription regulated by hypoxia in a manner independent of hypoxia‐inducible factors. There was an increased capillary length density but no difference in the total length of capillaries in the hearts of the chronically hypoxemic fetuses. Conclusion: The lack of upregulation of hypoxia target genes in response to chronic hypoxemia in the fetal heart in late gestation may be due to a decrease in the number of cardiomyocytes (decreased oxygen demand) and the maintenance of the total length of capillaries. Consequently, these adaptive responses in the fetal heart may maintain a normal oxygen tension within the cardiomyocyte of the chronically hypoxemic fetus in late gestation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.113.000531

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A growth-restricted fetus has smaller coronary arteries, fewer but more immature cardiomyocytes, less elastin in the arteries, and fewer nephrons in the kidney.

    “For example, a growth-restricted fetus has smaller coronary arteries (288), fewer but more immature cardiomyocytes (55,348,394), less elastin in the arteries (152, 362, 526), and fewer nephrons in the kidney (22,352).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [55]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Botting, K. J., McMillen, I. C., Forbes, H., Nyengaard, J. R., & Morrison, J. L.
Affiliations
  • University of South Australia (AU)
  • Aarhus University (DK)
Venue
Journal of the American Heart Association
Published
2014-08-15
Volume
3
Issue
4
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2104135702
Cited by
111
References
56
Citations by year
2026: 3 · 2025: 14 · 2024: 4 · 2023: 8 · 2022: 3 · 2021: 10 · 2020: 16 · 2019: 9 · 2018: 15 · 2017: 12 · 2016: 9 · 2015: 7 · 2014: 1
FWCI
10.27
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Heart Association (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
Funders
  • Villum Fonden
  • Medical Research Council
  • National Health and Medical Research Council (CR07A3328, CR10A4988, 511341)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
chronic hypoxemia, placental insufficiency, fetal growth restriction, cardiomyocyte number, fetal heart development, cardiomyocyte apoptosis, hypoxia-responsive genes, hypoxia-inducible factor, autophagy, p53, protein kinase C epsilon, angiogenesis-related genes, late pregnancy
MeSH terms
Animals, Hypoxia, Cell Count, Female, Placental Insufficiency, Pregnancy, RNA, Messenger, Sheep, Tumor Suppressor Protein p53, Apoptosis, Gene Expression Regulation, Developmental, Genes, bcl-2, Myocytes, Cardiac, Vascular Endothelial Growth Factor A, Apoptosis Regulatory Proteins, bcl-2-Associated X Protein, Glucose Transporter Type 1, Glucose Transporter Type 3, Lysosomal-Associated Membrane Protein 1, Nitric Oxide Synthase Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review